David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.33% |
| 2 | Technology | 14.87% |
| 3 | Consumer Discretionary | 9.92% |
| 4 | Healthcare | 7.34% |
| 5 | Financials | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GGMC
2176
DELISTED
Glenfarne Merger Corp. Class A Common Stock
GGMC
| $4.05M | ﹤0.01% |
+418,241
| New | +$4.06M |
|
|
FRW
2177
DELISTED
PWP Forward Acquisition Corp. I Class A Common Stock
FRW
| $4.05M | ﹤0.01% |
421,276
+171,276
| +69% | +$1.67M |
|
|
SFIX
2178
PUT
Stitch Fix
SFIX
$408M
| $4.05M | ﹤0.01% |
101,300
+91,300
| +913% | +$4.27M |
|
2179
Interface
TILE
$2.19B
| $4.04M | ﹤0.01% |
266,931
-110,754
| -29% | -$1.59M |
|
2180
Brunswick
BC
$5.08B
| $4.04M | ﹤0.01% |
42,416
+25,362
| +149% | +$2.52M |
|
2181
Robert Half
RHI
$4.6B
| $4.04M | ﹤0.01% |
40,277
+36,642
| +1,008% | +$3.59M |
|
|
ZFOX
2182
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
| $4.03M | ﹤0.01% |
403,042
+218,595
| +119% | +$2.18M |
|
2183
Prudential Financial
PRU
$41.5B
| $4.02M | ﹤0.01% |
38,247
-69,343
| -64% | -$7.15M |
|
|
ZWRK
2184
DELISTED
Z-Work Acquisition Corp. Class A Common Stock
ZWRK
| $4.02M | ﹤0.01% |
+413,032
| New | +$3.99M |
|
2185
Tonix Pharmaceuticals
TNXP
$236M
| $4.02M | ﹤0.01% |
10
+9
| +900% | +$4.38M |
|
|
BSKY
2186
DELISTED
Big Sky Growth Partners, Inc. Class A Common Stock
BSKY
| $4.01M | ﹤0.01% |
+410,569
| New | +$4.01M |
|
2187
CALL
BlackLine
BL
$1.94B
| $4.01M | ﹤0.01% |
34,000
+20,000
| +143% | +$2.3M |
|
|
KAMN
2188
DELISTED
Kaman Corp
KAMN
| $4.01M | ﹤0.01% |
112,517
+79,444
| +240% | +$3.28M |
|
2189
PUT
Wolfspeed
WOLF
$1.39B
| $4.01M | ﹤0.01% |
49,700
+38,700
| +352% | +$3.44M |
|
2190
Galicia Financial Group
GGAL
$6.91B
| $4M | ﹤0.01% |
397,096
+98,190
| +33% | +$899K |
|
|
RXRA
2191
DELISTED
RXR Acquisition Corp. Class A Common Stock
RXRA
| $4M | ﹤0.01% |
411,357
+278,024
| +209% | +$2.71M |
|
2192
CALL
FIVE9
FIVN
$2.53B
| $3.99M | ﹤0.01% |
25,000
+15,000
| +150% | +$2.74M |
|
2193
CALL
Fair Isaac
FICO
$25B
| $3.98M | ﹤0.01% |
10,000
| – | – |
|
|
RAPT
2194
DELISTED
RAPT Therapeutics
RAPT
| $3.97M | ﹤0.01% |
15,971
+9,986
| +167% | +$2.64M |
|
2195
Entravision Communication
EVC
$746M
| $3.96M | ﹤0.01% |
557,966
-377,200
| -40% | -$2.55M |
|
2196
Ascendis Pharma A/S
ASND
$16.3B
| $3.96M | ﹤0.01% |
24,827
+18,710
| +306% | +$2.56M |
|
2197
Envoy Medical
COCH
$56M
| $3.95M | ﹤0.01% |
407,316
+307,316
| +307% | +$2.98M |
|
|
TMX
2198
DELISTED
Terminix Global Holdings, Inc.
TMX
| $3.95M | ﹤0.01% |
94,789
+39,910
| +73% | +$1.84M |
|
|
FSRX
2199
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
| $3.94M | ﹤0.01% |
404,779
+288,426
| +248% | +$2.8M |
|
|
LCAA
2200
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
| $3.94M | ﹤0.01% |
404,708
+127,923
| +46% | +$1.24M |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $13.7B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.